Zevra Therapeutics (ZVRA) EBIT (2014 - 2026)
Zevra Therapeutics' EBIT came in at $11.58 million for Q3 2026, up 179.5% from $4.14 million a year earlier but down 31.0% from the prior quarter.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) EBIT (2014 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Zevra Therapeutics reported EBIT of $89.82 million; for FY2025, it was -$62.94 million.
- Going back by year, EBIT was -$87 million in FY2024, -$49.6 million in FY2023, -$42.57 million in FY2022 and $7.73 million in FY2021.
- The five-year range for quarterly EBIT is -$71.04 million (Q2 2025) to $52.15 million (Q1 2026).
- Business Quant data shows ZVRA's EBIT at $16.78 million (Q2 2026), $52.15 million (Q1 2026) and $9.32 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 8.41 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 6.18 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 6.27 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.56 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.39 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 3.71 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 3.46 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.47 Bn |
| 10 | Zevra Therapeutics | 708.52 Mn | -100.24 Mn | 36.01 Mn | 11.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 11.58 Mn |
| Jun 30, 2026 | 16.78 Mn |
| Mar 31, 2026 | 52.15 Mn |
| Dec 31, 2025 | 9.32 Mn |
| Sep 30, 2025 | 4.14 Mn |
| Jun 30, 2025 | -71.04 Mn |
| Mar 31, 2025 | -5.36 Mn |
| Dec 31, 2024 | -15.42 Mn |
| Sep 30, 2024 | -27.31 Mn |
| Jun 30, 2024 | -23.80 Mn |
| Mar 31, 2024 | -20.49 Mn |
| Dec 31, 2023 | -15.16 Mn |
| Sep 30, 2023 | -15.36 Mn |
| Jun 30, 2023 | -6.25 Mn |
| Mar 31, 2023 | -12.83 Mn |
| Dec 31, 2022 | -9.31 Mn |
| Sep 30, 2022 | -6.63 Mn |
| Jun 30, 2022 | -24.77 Mn |
| Mar 31, 2022 | -1.86 Mn |
| Dec 31, 2021 | -2.84 Mn |
API Access
Zevra Therapeutics EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=ZVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();